PillRx only · Injection, Powder, Lyophilized, For Solution · Intravenous
Velaglucerase Alfa
Brands: Vpriv · Velaglucerase Alfa
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
240
Rx · 2026 Q1
3.5K
Units dispensed
-27%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Takeda Pharmaceuticals America, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 14, 2014RECALLRecall (Class I): VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies,…
Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate. — Recalling firm: Shire Human Genetic Therapies, Inc. — US Nationwide including Puerto Rico; Mexico, Columbia